EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural MRI across lifespan reveals differential thalamic trajectories in Down syndrome

Muhammad Shaikh iD, Paul Fletcher, Shahid Zaman, Alzheimer's Biomarker Consortium on Down Syndrome, Stephanie Brown

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Muhammad Shaikh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Cambridge, Cambridge, Cambridgeshire, UK. Hauptthemen laut MEDLINE: Down Syndrome, Thalamus, Magnetic Resonance Imaging. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIHR Cambridge Biomedical Research Centre, Alzheimer's Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Up to 90% of Down syndrome (DS) patients develop Alzheimer's disease (AD). Sleep disturbance, affecting over 75% of DS patients, is implicated in AD pathogenesis. The thalamus, central to sleep and arousal, shows early vulnerability in DS‐related AD. METHODS Structural 3T MRI scans from 253 DS participants (119 males, mean age 43.0 ± 9.4 years) and 36 controls (30 males, mean age 43.1 ± 12.2 years) from the Alzheimer's Biomarker Consortium‐Down Syndrome (ABC‐DS) study were analyzed, alongside neurodegenerative plasma biomarker assays (phosphorylated tau [pTau]181, pTau217, neurofilament light chain [NfL], amyloid beta [Aβ]40, Aβ42). RESULTS In DS, intracranial volume‐adjusted thalamic volume declined with age ( t = −2.589, p = 0.00987), approximating 2.5% loss per decade. This was linear, gray matter involution‐independent, and heterogeneous across nuclei, correlating negatively with pTau and NfL. Controls exhibited no significant volumetric changes. DISCUSSION Anteromedial and posterior thalamic shrinkage in DS AD mirrors sporadic AD. Associations with neurodegenerative biomarkers support thalamic atrophy as a sensitive marker of DS‐related AD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeThalamusMagnetic Resonance ImagingHumansMaleFemaleMiddle AgedAdultBiomarkerstau ProteinsAmyloid beta-PeptidesAlzheimer DiseaseNeurofilament Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseDown syndromePapez Networkneurodegenerationthalamus

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesNeurofilament Proteins

Autor:innen und Institutionen

  • Department of Psychiatry, University of Cambridge, Cambridge, Cambridgeshire, UK.
  • Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn Hospital, Cambridge, Cambridgeshire, UK.

ORCID-Profile: Muhammad Shaikh

Förderung

  • NIA NIH HHS
  • NIHR Cambridge Biomedical Research Centre
  • Alzheimer's Research UK

Zitieren

APA

Shaikh, M., Fletcher, P., Zaman, S., Alzheimer's Biomarker Consortium on Down Syndrome, & Brown, S. (2026). Structural MRI across lifespan reveals differential thalamic trajectories in Down syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71671

Vancouver

Shaikh M, Fletcher P, Zaman S, Alzheimer's Biomarker Consortium on Down Syndrome, Brown S. Structural MRI across lifespan reveals differential thalamic trajectories in Down syndrome. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71671

BibTeX
@article{Shaikh2026,
  author = {Shaikh, Muhammad and Fletcher, Paul and Zaman, Shahid and Alzheimer's Biomarker Consortium on Down Syndrome, Alzheimer's Biomarker Consortium on Down Syndrome and Brown, Stephanie},
  title = {Structural MRI across lifespan reveals differential thalamic trajectories in Down syndrome},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71671}
}
Kostenlos starten →